Our data, however, add to a large body of work supporting an anti-tumor effect of the t10c12 CLA isomer and warrant further investigation in the prevention and treatment of breast tumors overexpressing HER2/neu and NF-κB. This evidence concerns the gene NFKB1 and breast neoplasm.